Projects per year
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Projects 2018 2024
- 4 Active
An Open-Label, Multicenter, Phase I/Ib Trial Evaluating the Safety and Pharmacokinetics of Escalating Doses of Btct4465a A Single Agent and Combined with Atezolizumab in Patients with Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia
Patil, S. & Kennedy, N.
6/03/19 → 31/12/22
Project: Research
A Phase 1 First-in-Human Study of Bispecific Antibody TG-1801 in Subjects with B-Cell Lymphoma.
Patil, S. & Kennedy, N.
20/02/19 → 29/02/24
Project: Research
Study of using Cyclophosphamide After Sibling-donor allogenic stem-cell Transplantation (CAST) in patients with acute leukaemia and Myelodysplasia: a randomised study comparing cyclosporin and methotrexate to cyclosporin and post-transplantation cyclophosphamide for graft-versus-host disease prophylaxis.
Patil, S., Curtis, D. & Kennedy, N.
23/10/18 → 23/10/23
Project: Research
CAST – A Randomised Phase 3 Trial of Cyclophosphamide after Sibling Allogeneic Haematopoietic Stem Cell Transplant
Curtis, D., Hill, G. R., Gottlieb, D., Patil, S., Ritchie, D., King, M. & Morrissey, O.
13/06/18 → 31/12/22
Project: Research
Research Output 2008 2018
Contemporary analysis of functional immune recovery to opportunistic and vaccine-preventable infections after allogeneic haemopoietic stem cell transplantation
De Silva, H., Ffrench, R. A., Korem, M., Orlowski-Oliver, E., Curtis, D. J., Spencer, A., Avery, S., Patil, S. & Morrissey, C. O., 1 Jan 2018, In : Clinical and Translational Immunology. 7, 10, 16 p., e1040.Research output: Contribution to journal › Article › Research › peer-review
Open Access
File
Adverse impact of high donor CD3+ cell dose on outcome following tandem auto-NMA allogeneic transplantation for high-risk myeloma
Nair, A. P., Walker, P., Kalff, A., Bergin, K., Hocking, J., Avery, S., Curtis, D. J., Patil, S., Das, T., Klarica, D., Morgan, S., Muirhead, J., Gorniak, M. B., Reynolds, J. & Spencer, A., 1 Jun 2017, In : Bone Marrow Transplantation. 52, 6, p. 839-845 7 p.Research output: Contribution to journal › Article › Research › peer-review
An individualised risk-Adapted protocol of pre-and post transplant zoledronic acid reduces bone loss after allogeneic stem cell transplantation: Results of a phase II prospective trial
Grigg, A. P., Butcher, B., Khodr, B., Bajel, A., Hertzberg, M., Patil, S., D'Souza, A. B., Ganly, P., Ebeling, P. & Wong, E., 1 Sep 2017, In : Bone Marrow Transplantation. 52, 9, p. 1288-1293 6 p.Research output: Contribution to journal › Article › Research › peer-review
The mTOR inhibitor everolimus in combination with azacitidine in patients with relapsed/refractory acute myeloid leukemia: a phase Ib/II study
Tan, P., Tiong, I. S., Fleming, S., Pomilio, G., Cummings, N., Droogleever, M., McManus, J., Schwarer, A., Catalano, J., Patil, S., Avery, S., Spencer, A. & Wei, A., 2017, In : Oncotarget. 8, 32, p. 52269-52280 12 p.Research output: Contribution to journal › Article › Research › peer-review
Open Access
Comparison of biosimilar filgrastim with originator filgrastim for peripheral blood stem cell mobilization and engraftment in patients with multiple myeloma undergoing autologous stem cell transplantation
Pham, T., Patil, S., Fleming, S. A., Avery, S., Walker, P. A., Wei, A., Curtis, D. J., Stuart, G., Klarica, D., O'Brien, M., Morris, K., Das, T. P., Bollard, G. M., Muirhead, J., Coutsouvelis, J. & Spencer, A., 2015, In : Transfusion. 55, 11, p. 2709 - 2713 5 p.Research output: Contribution to journal › Article › Research › peer-review